Your browser doesn't support javascript.
loading
Final results of DIADEM, a phase II study to investigate the efficacy and safety of durvalumab in advanced pretreated malignant pleural mesothelioma.
Canova, S; Ceresoli, G L; Grosso, F; Zucali, P A; Gelsomino, F; Pasello, G; Mencoboni, M; Rulli, E; Galli, F; De Simone, I; Carlucci, L; De Angelis, A; Belletti, M; Bonomi, M; D'Aveni, A; Perrino, M; Bono, F; Cortinovis, D L.
Afiliación
  • Canova S; ASST H S Gerardo, SC Medical Oncology, Monza.
  • Ceresoli GL; Humanitas Gavazzeni, Bergamo; Department of Oncology, Saronno Hospital, ASST Valle Olona, Saronno (VA).
  • Grosso F; Mesothelioma Unit, Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria.
  • Zucali PA; Department of Oncology, IRCCS Humanitas Research Hospital, Rozzano; Department of Biomedical Sciences, Humanitas University, Rozzano.
  • Gelsomino F; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna.
  • Pasello G; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova; Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova.
  • Mencoboni M; ASL 3 Genovese-Ospedale Villa Scassi, Genova.
  • Rulli E; Methodology for Clinical Research Laboratory, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan.
  • Galli F; Methodology for Clinical Research Laboratory, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan.
  • De Simone I; Methodology for Clinical Research Laboratory, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan.
  • Carlucci L; Methodology for Clinical Research Laboratory, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan.
  • De Angelis A; Mesothelioma Unit, Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria.
  • Belletti M; Mesothelioma Unit, Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria.
  • Bonomi M; Humanitas Gavazzeni, Bergamo; Department of Oncology, ASST Cremona, Cremona, Italy.
  • D'Aveni A; Humanitas Gavazzeni, Bergamo; Department of Oncology, Saronno Hospital, ASST Valle Olona, Saronno (VA).
  • Perrino M; Department of Oncology, IRCCS Humanitas Research Hospital, Rozzano.
  • Bono F; ASST H S Gerardo, SC Medical Oncology, Monza.
  • Cortinovis DL; ASST H S Gerardo, SC Medical Oncology, Monza. Electronic address: d.cortinovis@asst-monza.it.
ESMO Open ; 7(6): 100644, 2022 12.
Article en En | MEDLINE | ID: mdl-36463732
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pleurales / Mesotelioma Maligno / Mesotelioma Idioma: En Revista: ESMO Open Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pleurales / Mesotelioma Maligno / Mesotelioma Idioma: En Revista: ESMO Open Año: 2022 Tipo del documento: Article